IP Verse

Substituted Dimeric Quinazoline Derivative, Its Preparation And Its Use In Pharmaceutical Compositions For The Treatment Of Type I And Ii Diabetes - EP3517539

PATENT ANALYSIS

Patent Details

Grant Date
Dec 14, 2022
Company
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions

HAMM&WITTKOPP PATENTANWALTE PARTMBB

KNPP PARTGMBB

MAIWALD GMBH

More patents of Boehringer Ingelheim International Gmbh

EP2313087

EP3110449

EP3802922

Want to monitor this patent?

Feel free to send us a message here and we will get back to you